USD 12.73
(3.66%)
Year | Total Debt | Total Debt Growth |
---|---|---|
2023 | 1.63 Billion USD | -0.32% |
2022 | 1.64 Billion USD | 40995.0% |
2021 | 4 Million USD | -20.0% |
2020 | 5 Million USD | 0.0% |
2019 | - USD | 0.0% |
Year | Total Debt | Total Debt Growth |
---|---|---|
2024 Q2 | 1.65 Billion USD | 1.13% |
2024 Q1 | 1.63 Billion USD | -0.08% |
2024 Q3 | 1.65 Billion USD | -0.18% |
2023 Q1 | 1.64 Billion USD | -0.08% |
2023 FY | 1.63 Billion USD | -0.32% |
2023 Q4 | 1.63 Billion USD | -0.09% |
2023 Q3 | 1.63 Billion USD | -0.07% |
2023 Q2 | 1.64 Billion USD | -0.09% |
2022 Q4 | 1.64 Billion USD | -0.09% |
2022 Q2 | 1.61 Billion USD | 0.0% |
2022 FY | 1.64 Billion USD | 40995.0% |
2022 Q3 | 1.64 Billion USD | 2.17% |
2022 Q1 | - USD | -100.0% |
2021 Q1 | - USD | 0.0% |
2021 FY | 4 Million USD | -20.0% |
2021 Q4 | 3 Million USD | 0.0% |
2020 FY | 5 Million USD | 0.0% |
2019 FY | - USD | 0.0% |
Name | Total Debt | Total Debt Difference |
---|---|---|
Esperion Therapeutics, Inc. | 540.94 Million USD | -202.895% |
Theratechnologies Inc. | 58.96 Million USD | -2678.626% |
Safety Shot Inc | 1.54 Million USD | -105679.697% |
Cosmos Health Inc. | 12.42 Million USD | -13088.235% |
Cronos Group Inc. | 2.53 Million USD | -64409.449% |
Ironwood Pharmaceuticals, Inc. | 715.53 Million USD | -128.989% |
Kala Pharmaceuticals, Inc. | 36.32 Million USD | -4410.916% |
Organogenesis Holdings Inc. | 119.35 Million USD | -1272.841% |
Universe Pharmaceuticals INC | 5.48 Million USD | -29786.241% |
ProPhase Labs, Inc. | 21.38 Million USD | -7563.704% |
Sonoma Pharmaceuticals, Inc. | 608 Thousand USD | -269390.132% |
Dynavax Technologies Corporation | 256.91 Million USD | -537.762% |
Radius Health, Inc. | 365.31 Million USD | -348.519% |
China SXT Pharmaceuticals, Inc. | 2.64 Million USD | -61789.626% |
Alvotech | 1.07 Billion USD | -52.351% |
Sunshine Biopharma, Inc. | 657.7 Thousand USD | -249023.847% |
Alpha Teknova, Inc. | 30.45 Million USD | -5279.539% |
Intra-Cellular Therapies, Inc. | 16.93 Million USD | -9573.515% |
SCYNEXIS, Inc. | 15.08 Million USD | -10765.385% |
Harrow Health, Inc. | 190.5 Million USD | -760.096% |
Biofrontera Inc. | 5.39 Million USD | -30248.213% |
DURECT Corporation | 20.74 Million USD | -7797.908% |
Supernus Pharmaceuticals, Inc. | 41.52 Million USD | -3845.626% |
ANI Pharmaceuticals, Inc. | 315.32 Million USD | -419.618% |
OptiNose, Inc. | 131.74 Million USD | -1143.653% |
RedHill Biopharma Ltd. | 1.17 Million USD | -139583.855% |
Aquestive Therapeutics, Inc. | 98.82 Million USD | -1558.032% |
Cumberland Pharmaceuticals Inc. | 18.42 Million USD | -8791.128% |
SIGA Technologies, Inc. | 1.46 Million USD | -111818.711% |
Lifecore Biomedical, Inc. | 130.36 Million USD | -1156.904% |
Shineco, Inc. | 29.65 Million USD | -5424.938% |
Phibro Animal Health Corporation | 525.45 Million USD | -211.823% |
Procaps Group S.A. | 285.93 Million USD | -473.032% |
TherapeuticsMD, Inc. | 8 Million USD | -20368.457% |
Regencell Bioscience Holdings Limited | 59.8 Thousand USD | -2739545.861% |
Viatris Inc. | 18.12 Billion USD | 90.959% |
Sunshine Biopharma, Inc. | 657.7 Thousand USD | -249023.847% |
Rockwell Medical, Inc. | 13.43 Million USD | -12092.127% |
Incannex Healthcare Limited | 373 Thousand USD | -439176.139% |
Aytu BioPharma, Inc. | 15.12 Million USD | -10730.194% |
Tilray Brands, Inc. | 387.31 Million USD | -323.038% |
Collegium Pharmaceutical, Inc. | 674.28 Million USD | -142.999% |
PetIQ, Inc. | 468.3 Million USD | -249.881% |
Silver Spike Investment Corp. | - USD | -Infinity% |
Neurocrine Biosciences, Inc. | 428.4 Million USD | -282.47% |
Journey Medical Corporation | 17.73 Million USD | -9141.399% |
Alimera Sciences, Inc. | 67.39 Million USD | -2331.045% |
Petros Pharmaceuticals, Inc. | 8.27 Million USD | -19696.798% |
Assertio Holdings, Inc. | 40.91 Million USD | -3904.937% |
Shuttle Pharmaceuticals Holdings, Inc. | 1.08 Million USD | -150539.794% |
Cyclo Therapeutics, Inc. | 1.03 Million USD | -158498.026% |
Procaps Group, S.A. | 285.93 Million USD | -473.032% |
PainReform Ltd. | 86 Thousand USD | -1905132.558% |
Avadel Pharmaceuticals plc | 35.38 Million USD | -4530.624% |
Hempacco Co., Inc. | 13.72 Million USD | -11838.5% |
Talphera, Inc. | - USD | -Infinity% |
Pacira BioSciences, Inc. | 586.04 Million USD | -179.587% |
Alvotech | 1.07 Billion USD | -52.351% |
Lantheus Holdings, Inc. | 616.94 Million USD | -165.582% |
Kamada Ltd. | 8.74 Million USD | -18627.882% |
Indivior PLC | 281.6 Million USD | -481.85% |
Currenc Group, Inc. | 31.94 Million USD | -5029.347% |
Evoke Pharma, Inc. | 5 Million USD | -32670.0% |
Flora Growth Corp. | 3.67 Million USD | -44521.46% |
Cyclo Therapeutics, Inc. | 1.03 Million USD | -158498.026% |
Evolus, Inc. | 126.54 Million USD | -1194.786% |
HUTCHMED (China) Limited | 86.13 Million USD | -1802.335% |
Amphastar Pharmaceuticals, Inc. | 623.64 Million USD | -162.731% |
Akanda Corp. | 3.99 Million USD | -40874.885% |